Braveheart Bio, Inc. BRVE
21.18 USD +0.14 (+0.67%)
Nov 3, 2026, 3:27 PM EST
20.24 Day range 21.53
17.86 52-week range 32.00
- YTD
- -28.93%
- 1 year
- -28.93%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 45.25 +113.6% upside
Now 21.18
- Target (low)
- 40.00
- Target (mean)
- 45.25
- Target (high)
- 48.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy0
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.438 | -0.91 – -0.21 | 0.00 | 0.0% | 0 | 0.0% | 5 |
| Next quarter | -0.284 | -0.47 – 0.35 | 0.00 | 0.0% | 0 | 0.0% | 5 |
| Current year | -1.78 | -2.94 – -0.65 | -17.21 | +89.7% | 0 | 0.0% | 5 |
| Next year | -1.62 | -2.34 – -1.10 | -1.78 | +8.9% | 0 | 0.0% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 20, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |